Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TECXTectonic Therapeutic, Inc.

Nasdaq · CIK 0001681087
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts345

Identity from submissions API

NameTectonic Therapeutic, Inc.
CIK0001681087
TickersTECX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN810710585
LEI—
Fiscal year end1231
State of incorporationNY NY
Phone(339) 666-3320
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • AvroBio, Inc. (2018-02-02T05:00:00.000Z → 2024-06-18T04:00:00.000Z)
  • AVROBIO, Inc. (2018-02-02T05:00:00.000Z → 2024-06-18T04:00:00.000Z)
Business address
490 ARSENAL WAY
SUITE 200
WATERTOWN
MA
MA
Mailing address
490 ARSENAL WAY
SUITE 200
WATERTOWN
MA
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

582 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-05 10-Q 10-Q 0001193125-26-450019 001-38537 261528050 34 10268424 1 1
2026-11-05 8-K 8-K 2.01,9.01 0001193125-26-449965 001-38537 261527840 34 370233 1 1
2026-10-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001716774-26-000024 005-90532 261498506 34 9135
2026-10-28 4 xslF345X06/form4-10282026_041002.xml 0001757533-26-000018 9328
2026-10-02 4 xslF345X06/form4-10022026_091013.xml 0001791187-26-000010 5238
2026-10-02 4 xslF345X06/form4-10022026_091039.xml 0002023255-26-000012 7423
2026-10-02 4 xslF345X06/form4-10022026_081032.xml 0002023849-26-000014 5245
2026-10-02 4 xslF345X06/form4-10022026_081054.xml 0001757533-26-000016 6604
2026-10-02 4 xslF345X06/form4-10022026_081032.xml 0002023175-26-000009 5240
2026-09-30 144 xsl144X01/primary_doc.xml 0001950047-26-009887 001-38537 261427403 33 6348
2026-09-29 8-K 8-K 8.01,9.01 0001193125-26-407823 001-38537 261424834 34 171454 1 1
2026-09-08 4 xslF345X06/form4-09082026_040909.xml 0002023175-26-000007 5902
2026-09-08 4 xslF345X06/form4-09082026_040907.xml 0002023255-26-000011 5904
2026-09-08 4 xslF345X06/form4-09082026_040905.xml 0001791187-26-000008 5900
2026-09-08 4 xslF345X06/form4-09082026_040903.xml 0002023849-26-000012 5907
2026-09-08 4 xslF345X06/form4-09082026_040901.xml 0001757533-26-000014 5913
2026-08-27 144 xsl144X01/primary_doc.xml 0001950047-26-008795 001-38537 261331884 33 5723
2026-08-26 4 xslF345X06/form4-08262026_040801.xml 0002023255-26-000009 9030
2026-08-21 144 xsl144X01/primary_doc.xml 0001950047-26-008563 001-38537 261305945 33 4976
2026-08-14 4 xslF345X06/form4-08142026_110840.xml 0002023255-26-000007 9027
2026-08-12 144 xsl144X01/primary_doc.xml 0001950047-26-008032 001-38537 261268117 33 5868
2026-08-06 10-Q 10-Q 0001193125-26-338062 001-38537 261249310 34 9768242 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-338000 001-38537 261249068 34 215513 1 1
2026-07-01 4 xslF345X06/form4-07012026_090747.xml 0002023255-26-000006 9031
2026-06-30 144 xsl144X01/primary_doc.xml 0001950047-26-006668 001-38537 261141076 33 4930
2026-06-23 4 xslF345X06/form4-06232026_090656.xml 0001757533-26-000012 6601
2026-06-12 4 xslF345X06/form4-06122026_040619.xml 0001791187-26-000006 6411
2026-06-10 8-K 8-K 5.07,8.01,9.01 0001193125-26-266040 001-38537 261080575 34 173954 1 1
2026-06-10 4 xslF345X06/form4-06102026_040607.xml 0001055624-26-000003 5902
2026-06-10 4 xslF345X06/form4-06102026_040605.xml 0001779978-26-000003 5915
2026-06-10 4 xslF345X06/form4-06102026_040603.xml 0001238120-26-000010 6041
2026-06-10 4 xslF345X06/form4-06102026_040601.xml 0001826967-26-000003 5954
2026-06-10 4 xslF345X06/form4-06102026_080616.xml 0002123815-26-000007 5871
2026-06-10 3 xslF345X06/form3-06102026_080602.xml 0002123815-26-000006 8682
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-212069 001-38537 26953901 34 299191 1 1
2026-05-07 10-Q 10-Q 0001193125-26-212016 001-38537 26953739 34 8974263 1 1
2026-05-06 4 xslF345X06/form4-05062026_050501.xml 0002023849-26-000008 5100
2026-04-24 ARS ARS 0001193125-26-177514 001-38537 26895137 34 793641
2026-04-24 DEFA14A DEFA14A 0001193125-26-177502 001-38537 26895096 34 944532
2026-04-24 DEF 14A DEF 14A 0001193125-26-177467 001-38537 26894940 34 2486325 1 1
2026-04-23 8-K 8-K 5.02,7.01,9.01 0001193125-26-173829 001-38537 26889102 34 161870 1 1
2026-04-03 4 xslF345X06/form4-04032026_080442.xml 0002023849-26-000006 5103
2026-04-03 4 xslF345X06/form4-04032026_080427.xml 0001365343-26-000003 5817
2026-04-03 3 xslF345X06/form3-04032026_080423.xml 0001365343-26-000002 8879
2026-03-09 4 xslF345X05/form4-03092026_100315.xml 0002023849-26-000004 4964
2026-03-09 4 xslF345X05/form4-03092026_100314.xml 0002023255-26-000005 14782
2026-03-09 S-8 POS S-8 POS 0001193125-26-098838 333-293899 26736215 33 45609
2026-03-06 144 xsl144X01/primary_doc.xml 0001950047-26-002325 001-38537 26731518 33 7113
2026-03-06 144 xsl144X01/primary_doc.xml 0001950047-26-002324 001-38537 26731511 33 4931
2026-03-05 4 xslF345X05/form4-03052026_100320.xml 0001757533-26-000009 8948
2026-03-05 4 xslF345X05/form4-03052026_100314.xml 0002023175-26-000005 7585
2026-03-05 4 xslF345X05/form4-03052026_100302.xml 0002023255-26-000004 10756
2026-03-05 4 xslF345X05/form4-03052026_100327.xml 0001791187-26-000005 7583
2026-03-05 4 xslF345X05/form4-03052026_100303.xml 0002023849-26-000003 7590
2026-03-05 4/A xslF345X05/form4a-03052026_040323.xml 0001757533-26-000008 7194
2026-03-04 144 xsl144X01/primary_doc.xml 0001950047-26-002195 001-38537 26722190 33 5640
2026-03-03 144 xsl144X01/primary_doc.xml 0001950047-26-002114 001-38537 26715511 33 4968
2026-02-27 S-8 S-8 0001193125-26-083260 333-293899 26702059 33 195825 1 1
2026-02-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-083202 005-90532 26701843 34 127575
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-076843 001-38537 26688989 34 364507 1 1
2026-02-26 10-K 10-K 0001193125-26-076793 001-38537 26688624 34 13421054 1 1
2026-02-24 8-K 8-K 5.02,7.01,9.01 0001193125-26-066964 001-38537 26671543 34 6528141 1 1
2026-02-12 4 xslF345X05/form4-02122026_040204.xml 0001757533-26-000005 6674
2026-02-12 4 xslF345X05/form4-02122026_040201.xml 0002023175-26-000003 7579
2026-02-11 4 xslF345X05/form4-02112026_100208.xml 0001791187-26-000003 5309
2026-02-10 4 xslF345X05/form4-02102026_090237.xml 0002023175-26-000002 5101
2026-02-10 4 xslF345X05/form4-02102026_090218.xml 0002023849-26-000002 5106
2026-02-10 4 xslF345X05/form4-02102026_090253.xml 0001757533-26-000004 6464
2026-02-10 4 xslF345X05/form4-02102026_090217.xml 0002023255-26-000002 5103
2026-02-10 4 xslF345X05/form4-02102026_090247.xml 0001791187-26-000002 5099
2026-01-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001716774-26-000007 005-90532 26577409 34 8859
2026-01-05 4 xslF345X05/form4-01052026_100128.xml 0001757533-26-000002 9201
2025-12-29 4 xslF345X05/form4-12292025_041201.xml 0002023255-25-000005 7568
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000706 005-90532 251486607 34 15389
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004835 005-90532 251481425 34 11501
2025-11-06 10-Q 10-Q 0001193125-25-269701 001-38537 251458872 34 9078032 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-269573 001-38537 251458509 34 342293 1 1
2025-10-30 8-K 8-K 8.01,9.01 0001193125-25-256958 001-38537 251431658 34 6820657 1 1
2025-09-29 4 xslF345X05/form4-09292025_050908.xml 0002023175-25-000003 7645
2025-09-29 4 xslF345X05/form4-09292025_050907.xml 0002023255-25-000003 7647
2025-09-29 4 xslF345X05/form4-09292025_050905.xml 0001791187-25-000003 8109
2025-09-29 4 xslF345X05/form4-09292025_050903.xml 0002023849-25-000003 7650
2025-09-29 4 xslF345X05/form4-09292025_050901.xml 0001757533-25-000004 8977
2025-08-07 8-K 8-K 2.02,7.01,9.01 0001193125-25-175567 001-38537 251195266 34 8096587 1 1
2025-08-07 10-Q 10-Q 0000950170-25-104974 001-38537 251193844 34 9073758 1 1
2025-07-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002258 333-288539 251126101 33 1955
2025-07-15 424B3 424B3 0001193125-25-159404 333-288539 251125385 33 388498
2025-07-11 CORRESP filename1.htm 0001193125-25-158193 7218
2025-07-10 UPLOAD filename1.pdf 0000000000-25-007282 333-288539 40311
2025-07-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002193 333-286133 251112197 33 1968
2025-07-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002190 333-280909 251112194 33 1968
2025-07-07 POS AM POS AM 0001193125-25-156209 333-280909 251108326 33 409295
2025-07-07 POS AM POS AM 0001193125-25-156196 333-286133 251108226 33 435849
2025-07-07 S-3 S-3 0001193125-25-156183 333-288539 251108128 33 1313236
2025-06-24 4 xslF345X05/form4-06242025_080636.xml 0001415889-25-018106 6484
2025-06-11 4 xslF345X05/form4-06112025_040615.xml 0001415889-25-016676 5934
2025-06-11 4 xslF345X05/form4-06112025_040613.xml 0001415889-25-016675 5847
2025-06-11 4 xslF345X05/form4-06112025_040610.xml 0001415889-25-016674 5903
2025-06-11 4 xslF345X05/form4-06112025_040608.xml 0001415889-25-016673 5808
2025-06-11 4 xslF345X05/form4-06112025_040604.xml 0001415889-25-016672 5795
2025-06-11 424B5 424B5 0001193125-25-139142 333-280909 251039996 33 38001
2025-06-11 424B5 424B5 0001193125-25-139140 333-286133 251039952 33 37985
2025-06-06 8-K 8-K 5.07 0001193125-25-137149 001-38537 251031409 34 151246 1 1
2025-05-19 424B5 424B5 0001193125-25-122540 333-280909 25965087 33 27660
2025-05-19 424B5 424B5 0001193125-25-122537 333-286133 25965066 33 27652
2025-05-19 8-K 8-K 8.01,9.01 0001193125-25-122511 001-38537 25964828 34 176027 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000368 005-90532 25951447 34 16072
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001582 005-90532 25933362 34 11816
2025-05-08 424B3 424B3 0001193125-25-116019 333-280909 25926855 33 939750
2025-05-08 424B3 424B3 0001193125-25-116014 333-286133 25926839 33 939702
2025-05-08 10-Q 10-Q 0000950170-25-067037 001-38537 25926527 34 8114775 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066932 001-38537 25926030 34 288974 1 1
2025-04-25 ARS ARS 0001193125-25-096876 001-38537 25874286 34 2131689
2025-04-25 DEFA14A DEFA14A 0001193125-25-096828 001-38537 25874120 34 627174
2025-04-25 DEF 14A DEF 14A 0001193125-25-096764 001-38537 25874001 34 2446998 1 1
2025-04-11 4 xslF345X05/form4-04112025_100403.xml 0001415889-25-010588 18882
2025-04-09 4 xslF345X05/form4-04092025_090407.xml 0001415889-25-010499 7511
2025-04-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-029553 005-90532 25819377 34 13724
2025-04-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-051678 005-90532 25819053 34 22887
2025-04-07 4 4 0000950170-25-051671 8673
2025-04-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-051604 005-90532 25818382 34 12807
2025-04-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000964 333-280909 25811888 33 1967
2025-04-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000952 333-286133 25807309 33 1954
2025-03-31 CORRESP filename1.htm 0001193125-25-068729 7098
2025-03-31 UPLOAD filename1.pdf 0000000000-25-003416 333-286133 40335
2025-03-27 POS AM POS AM 0001193125-25-064222 333-280909 25774995 33 10594688 1 1
2025-03-26 S-1 S-1 0001193125-25-064163 333-286133 25774229 33 10673443 1 1
2025-03-20 S-8 S-8 0001193125-25-059371 333-285976 25757377 33 85905
2025-03-20 10-K 10-K 0000950170-25-042648 001-38537 25756475 34 14329229 1 1
2025-03-20 8-K 8-K 2.02,9.01 0000950170-25-042630 001-38537 25756395 34 345402 1 1
2025-02-14 D xslFormDX01/primary_doc.xml 06b 0001231919-25-000022 021-538387 25630324 33 17509
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-25-000012 005-90532 25619665 34 6571
2025-02-12 424B5 424B5 0001193125-25-025168 333-280909 25615722 33 35587
2025-02-12 424B5 424B5 0001193125-25-025158 333-280909 25615610 33 27522
2025-02-12 424B3 424B3 0001193125-25-025153 333-280909 25615537 33 1107360
2025-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000616 005-90532 25605706 34 11544
2025-02-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-011462 005-90532 25603570 34 14664
2025-02-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-016480 005-90532 25603072 34 18041
2025-02-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-016399 005-90532 25602622 34 26380
2025-02-07 4 xslF345X05/form4-02072025_090214.xml 0001415889-25-003351 8090
2025-02-07 4 xslF345X05/form4-02072025_090225.xml 0001415889-25-003350 5279
2025-02-06 4 xslF345X05/form4-02062025_040210.xml 0001415889-25-003229 7646
2025-02-06 4 xslF345X05/form4-02062025_040208.xml 0001415889-25-003228 7648
2025-02-06 4 xslF345X05/form4-02062025_040206.xml 0001415889-25-003227 7601
2025-02-06 4 xslF345X05/form4-02062025_040203.xml 0001415889-25-003226 7651
2025-02-06 4 xslF345X05/form4-02062025_040201.xml 0001415889-25-003225 8977
2025-02-03 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-25-018840 001-38537 25580524 34 566286 1 1
2025-01-30 8-K 8-K 7.01,8.01,9.01 0001193125-25-016224 001-38537 25571097 34 11029055 1 1
2025-01-29 4 xslF345X05/form4-01292025_040101.xml 0001415889-25-002262 7614
2025-01-13 8-K 8-K 7.01,9.01 0001193125-25-005304 001-38537 25526360 34 17567688 1 1
2025-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000026 005-90532 25516857 34 11730
2024-12-11 4 xslF345X05/form4-12112024_091246.xml 0001415889-24-028948 7615
2024-12-06 4 xslF345X05/form4-12062024_101244.xml 0001415889-24-028516 9334
2024-12-05 4 xslF345X05/form4-12052024_091203.xml 0001415889-24-028404 7681
2024-11-14 SC 13G/A formsc13ga.htm 0001493152-24-045820 005-90532 241461825 34 66929
2024-11-12 10-Q 10-Q 0000950170-24-125304 001-38537 241447756 34 7922101 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123411 001-38537 241436270 34 297618 1 1
2024-10-28 SC 13D/A SC 13D/A 0001104659-24-111899 005-90532 241402165 34 121835
2024-10-24 SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001213900-24-090440 005-90532 241393436 34 67702
2024-10-24 4 xslF345X05/form4-10242024_091007.xml 0001415889-24-025603 6691
2024-09-26 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-24-082376 005-90532 241330278 34 121194
2024-09-26 4 xslF345X05/form4-09262024_100948.xml 0001415889-24-024003 16822
2024-09-19 8-K 8-K 7.01,9.01 0001193125-24-222189 001-38537 241311213 34 24640844 1 1
2024-08-27 S-8 POS S-8 POS 0001193125-24-207748 333-281690 241248936 33 39607
2024-08-21 S-8 S-8 0001193125-24-204504 333-281690 241229428 33 104341
2024-08-14 8-K 8-K 2.02,9.01 0001193125-24-200629 001-38537 241207840 34 219183 1 1
2024-08-14 424B3 424B3 0001193125-24-200615 333-280909 241207406 33 1216424
2024-08-14 10-Q 10-Q 0001193125-24-200609 001-38537 241207331 34 6938450 1 1
2024-07-31 424B5 424B5 0001193125-24-189184 333-280909 241159620 33 33808
2024-07-30 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-07-30 16:00:00 9999999995-24-002323 333-280909 241159661 33 1962
2024-07-30 8-K 8-K 7.01,8.01,9.01 0001193125-24-188881 001-38537 241157580 34 24480468 1 1
2024-07-30 424B3 424B3 0001193125-24-188872 333-280909 241157518 33 13969331
2024-07-26 CORRESP filename1.htm 0001193125-24-186209 7256
2024-07-26 UPLOAD filename1.pdf 0000000000-24-008483 333-280909 40257
2024-07-22 SC 13G/A 13GA FMR 0000315066-24-001844 005-90532 241131061 34 8072
2024-07-19 S-1 S-1 0001193125-24-181624 333-280909 241127824 33 30203565 1 1
2024-07-10 SC 13G filing.txt 0000315066-24-001828 005-90532 241108967 34 8226
2024-07-05 8-K 8-K 5.02,9.01 0001193125-24-175599 001-38537 241102684 34 204154 1 1
2024-07-01 SC 13G tecx13g.htm 0000935836-24-000465 005-90532 241091230 34 48041
2024-06-27 SC 13D SC 13D 0001104659-24-075687 005-90532 241079639 34 82940
2024-06-26 SC 13D SCHEDULE 13D 0001213900-24-055917 005-90532 241070637 34 80748
2024-06-26 8-K 8-K 7.01,8.01,9.01 0001193125-24-168273 001-38537 241070479 34 15189556 1 1
2024-06-25 SC 13D SC 13D 0001193125-24-167893 005-90532 241069263 34 175892
2024-06-25 4 xslF345X05/form4.xml 0001373604-24-000039 8296
2024-06-24 4 xslF345X05/form4-06242024_080629.xml 0001415889-24-017998 11199
2024-06-24 4 xslF345X05/form4-06242024_080632.xml 0001415889-24-017995 11304
2024-06-24 3 xslF345X02/form3-06242024_080645.xml 0001415889-24-017994 8849
2024-06-24 4 xslF345X05/form4-06242024_080630.xml 0001415889-24-017992 11400
2024-06-24 3 xslF345X02/form3-06242024_080638.xml 0001415889-24-017991 8796
2024-06-24 4 xslF345X05/form4-06242024_080610.xml 0001415889-24-017984 10490
2024-06-24 3 xslF345X02/form3-06242024_080627.xml 0001415889-24-017977 8753
2024-06-24 4 xslF345X05/form4-06242024_080618.xml 0001415889-24-017975 14210
2024-06-24 3 xslF345X02/form3-06242024_080634.xml 0001415889-24-017974 8856
2024-06-24 4 xslF345X05/form4-06242024_080616.xml 0001415889-24-017972 11566
2024-06-24 3 xslF345X02/form3-06242024_080629.xml 0001415889-24-017970 8859
2024-06-24 4 xslF345X05/form4-06242024_080626.xml 0001415889-24-017964 14093
2024-06-24 3 xslF345X02/form3-06242024_080631.xml 0001415889-24-017963 8821
2024-06-24 4 xslF345X05/form4-06242024_080611.xml 0001415889-24-017962 16809
2024-06-24 3 xslF345X02/form3-06242024_080621.xml 0001415889-24-017961 8860
2024-06-24 4 xslF345X05/form4-06242024_080618.xml 0001415889-24-017958 5771
2024-06-24 3 xslF345X02/form3-06242024_080635.xml 0001415889-24-017955 8747
2024-06-24 4 xslF345X05/form4-06242024_080632.xml 0001415889-24-017954 11714
2024-06-24 3 xslF345X02/form3-06242024_080647.xml 0001415889-24-017953 8754
2024-06-24 4 xslF345X05/form4-06242024_080648.xml 0001415889-24-017952 17118
2024-06-24 3 xslF345X02/form3-06242024_080658.xml 0001415889-24-017951 8767
2024-06-20 8-K 8-K 1.01,2.01,2.02,3.02,3.03,4.01,5.01,5.02,5.03,5.06,8.01,9.01 0001193125-24-164480 001-38537 241056600 34 2224641 1 1
2024-06-18 8-K/A FORM 8-K/A 8.01 0001193125-24-163207 001-38537 241050685 34 162429 1 1
2024-06-14 8-K 8-K 8.01 0001193125-24-161663 001-38537 241045351 34 156366 1 1
2024-06-11 8-K 8-K 5.07 0001193125-24-159168 001-38537 241036184 34 179625 1 1
2024-06-04 425 425 0001193125-24-153750 001-38537 241016248 34 439034
2024-06-04 8-K 8-K 8.01 0001193125-24-153749 001-38537 241016244 34 772554 1 1
2024-06-03 425 425 0001193125-24-153237 001-38537 241015039 34 19289
2024-05-28 425 425 0001193125-24-148086 001-38537 24991737 34 24942
2024-05-21 425 425 0001193125-24-144023 001-38537 24970319 34 25377
2024-05-21 SC 13G/A avro13g020724.htm 0001373604-24-000030 005-90532 24967286 34 80855
2024-05-15 4 xslF345X05/form4.xml 0001373604-24-000022 9466
2024-05-15 3/A xslF345X02/form3.xml 0001373604-24-000020 4918
2024-05-15 3 xslF345X02/form3.xml 0001373604-24-000016 4272
2024-05-09 10-Q 10-Q 0000950170-24-057091 001-38537 24931239 34 6232569 1 1
2024-05-07 SEC STAFF LETTER filename1.pdf 9999999997-24-002570 64208
2024-05-03 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2024-05-03 16:15:00 9999999995-24-001368 333-277048 24915363 33 1839
2024-05-03 424B3 424B3 0001193125-24-130818 333-277048 24913838 33 8036012
2024-05-02 CORRESP filename1.htm 0001193125-24-129381 7587
2024-04-29 CORRESP filename1.htm 0001193125-24-122677 25075
2024-04-29 S-4/A S-4/A 0001193125-24-122672 333-277048 24892170 33 16313431 1 1
2024-04-24 SEC STAFF LETTER filename1.pdf 9999999997-24-002663 64747
2024-04-24 UPLOAD filename1.pdf 0000000000-24-004577 333-277048 46518
2024-04-15 CORRESP filename1.htm 0001193125-24-095519 56542
2024-04-15 S-4/A S-4/A 0001193125-24-095517 333-277048 24843120 33 18018581 1 1
2024-04-08 UPLOAD filename1.pdf 0000000000-24-003736 333-277048 63500
2024-04-04 425 425 0001193125-24-086650 001-38537 24821703 34 15700219
2024-03-26 S-4/A S-4/A 0001193125-24-076669 333-277048 24780438 33 18938076 1 1
2024-03-25 CORRESP filename1.htm 0001193125-24-076673 180838
2024-03-14 10-K 10-K 0000950170-24-031635 001-38537 24751175 34 9940324 1 1
2024-03-12 UPLOAD filename1.pdf 0000000000-24-002720 333-277048 127465
2024-02-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001758866-24-000003 005-90532 24671007 34 28849
2024-02-14 SC 13G formsc13g.htm 0001493152-24-006613 005-90532 24637782 34 61646
2024-02-14 SC 13G/A AMENDMENT NO. 1 0001214659-24-002861 005-90532 24637382 34 78119
2024-02-14 S-4 S-4 0001193125-24-034461 333-277048 24631618 33 26936846 1 1
2024-02-13 SC 13G/A AMENDMENT TO FORM SC 13G 0001999371-24-002064 005-90532 24624670 34 75054
2024-02-07 SC 13G/A avro13g020724.htm 0001616824-24-000019 005-90532 24602746 34 80929
2024-02-05 4 PRIMARY DOCUMENT 0001127602-24-003481 8498
2024-02-05 4 PRIMARY DOCUMENT 0001127602-24-003478 8193
2024-02-05 4 PRIMARY DOCUMENT 0001127602-24-003477 8206
2024-02-05 4 PRIMARY DOCUMENT 0001127602-24-003476 8156
2024-01-30 425 425 0001193125-24-019487 001-38537 24578851 34 62742
2024-01-30 425 425 0001193125-24-019414 001-38537 24578203 34 15506963
2024-01-30 8-K FORM 8-K 7.01,9.01 0001193125-24-019406 001-38537 24578156 34 15650872 1 1
2024-01-30 425 425 0001193125-24-018852 001-38537 24576026 34 16449916
2024-01-30 8-K FORM 8-K 1.01,5.01,5.02,7.01,9.01 0001193125-24-018812 001-38537 24575972 34 1341602 1 1
2024-01-24 SC 13G/A avro_13ga.htm 0000908834-24-000020 005-90532 24554731 34 414557
2023-11-09 10-Q 10-Q 0000950170-23-062131 001-38537 231393065 34 8071236 1 1
2023-11-03 RW RW 0001140361-23-051412 333-268255 231376502 NE 7292
2023-08-10 10-Q 10-Q 0000950170-23-041408 001-38537 231160096 34 9979513 1 1
2023-07-24 SC 13G NONE 0001567619-23-006661 005-90532 231104904 34 82650
2023-07-14 144 xsl144X01/primary_doc.xml 0001972362-23-000478 001-38537 231089596 33 5384
2023-07-12 8-K 8-K 2.05,7.01,9.01 0001140361-23-034121 001-38537 231083251 34 190441 1 1
2023-07-03 4 PRIMARY DOCUMENT 0001127602-23-019705 5208
2023-06-14 8-K/A 8-K/A 2.05 0001140361-23-029869 001-38537 231015096 34 175207 1 1
2023-06-13 8-K 8-K 8.01 0001140361-23-029620 001-38537 231011748 34 165728 1 1
2023-06-13 4 PRIMARY DOCUMENT 0001127602-23-018660 6319
2023-06-12 8-K 8-K 1.02,2.01,5.02,7.01,9.01 0001140361-23-029221 001-38537 231007083 34 465088 1 1
2023-06-09 8-K 8-K 5.02,5.07 0001140361-23-029124 001-38537 231005378 34 180048 1 1
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018296 5241
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018290 5341
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018287 5239
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018286 5208
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018283 5721
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018282 5236
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018280 5217
2023-06-07 144 xsl144X01/primary_doc.xml 0001969223-23-000155 001-38537 23998276 33 8040
2023-06-06 SC 13G g526230sc13g.htm 0001214659-23-008294 005-90532 23996024 34 86132
2023-06-05 144 xsl144X01/primary_doc.xml 0001969223-23-000152 001-38537 23992859 33 6884
2023-05-25 144 xsl144X01/primary_doc.xml 0001969223-23-000132 001-38537 23960838 33 6811
2023-05-24 144 xsl144X01/primary_doc.xml 0001969223-23-000128 001-38537 23954287 33 4361
2023-05-24 144 xsl144X01/primary_doc.xml 0001969223-23-000126 001-38537 23953573 33 4413
2023-05-24 144 xsl144X01/primary_doc.xml 0001969223-23-000125 001-38537 23953518 33 4438
2023-05-22 8-K 8-K 1.01,2.05,7.01,9.01 0001140361-23-025867 001-38537 23942411 34 205001 1 1
2023-05-18 8-K 8-K 7.01,9.01 0001140361-23-025377 001-38537 23933689 34 2731874 1 1
2023-05-11 10-Q 10-Q 0000950170-23-021318 001-38537 23911602 34 7243426 1 1
2023-05-11 8-K 8-K 2.02,9.01 0001140361-23-024002 001-38537 23908812 34 274048 1 1
2023-05-05 ARS ARS 0000950170-23-018296 001-38537 23893629 34 12663056
2023-05-01 DEF 14A DEF 14A 0000950170-23-016320 001-38537 23874766 34 4599762
2023-05-01 8-K FORM 8-K 5.02,7.01,9.01 0001140361-23-021828 001-38537 23870045 34 201953 1 1
2023-03-23 S-8 S-8 0001140361-23-013454 333-270799 23756930 33 75717
2023-03-23 10-K 10-K 0000950170-23-009527 001-38537 23756723 34 11077575 1 1
2023-03-23 8-K 8-K 2.02,9.01 0001140361-23-013237 001-38537 23754453 34 301334 1 1
2023-02-27 8-K 8-K 8.01 0001140361-23-008899 001-38537 23675675 34 164708 1 1
2023-02-17 SC 13G 13g_avro.htm 0001175707-23-000089 005-90532 23642128 34 580803
2023-02-10 4 PRIMARY DOCUMENT 0001127602-23-004515 5144
2023-02-10 4 PRIMARY DOCUMENT 0001127602-23-004512 5185
2023-02-10 4 PRIMARY DOCUMENT 0001127602-23-004511 5191
2023-02-10 4 PRIMARY DOCUMENT 0001127602-23-004510 5169
2023-02-10 4 PRIMARY DOCUMENT 0001127602-23-004509 5229
2023-02-10 4 PRIMARY DOCUMENT 0001127602-23-004508 5149
2023-02-08 SC 13G/A AVRO_13GA_20230207.htm 0001461790-23-000001 005-90532 23596580 34 106366
2023-01-26 4 PRIMARY DOCUMENT 0001127602-23-002332 12326
2023-01-19 SC 13G/A SCHEDULE 13G - AVROBIO, INC. 0001106191-23-000007 005-90532 23538131 34 110119
2022-12-28 4 PRIMARY DOCUMENT 0001127602-22-028329 8827
2022-12-09 4 PRIMARY DOCUMENT 0001127602-22-027239 5233
2022-12-09 4 PRIMARY DOCUMENT 0001127602-22-027236 5195
2022-12-09 4 PRIMARY DOCUMENT 0001127602-22-027235 5277
2022-12-09 4 PRIMARY DOCUMENT 0001127602-22-027233 5239
2022-12-09 4 PRIMARY DOCUMENT 0001127602-22-027231 5217
2022-12-09 4 PRIMARY DOCUMENT 0001127602-22-027230 5197
2022-12-07 8-K 8-K 7.01,9.01 0001140361-22-044662 001-38537 221449134 34 29833539 1 1
2022-11-08 S-3 S-3 0001140361-22-040534 333-268255 221369958 33 1931471
2022-11-08 10-Q 10-Q 0000950170-22-023269 001-38537 221369386 34 7539359 1 1
2022-11-08 8-K FORM 8-K 2.02,9.01 0001140361-22-040396 001-38537 221367200 34 284588 1 1
2022-10-07 8-K 8-K 3.01 0001140361-22-036649 001-38537 221301033 34 169664 1 1
2022-08-09 S-8 S-8 0001140361-22-028909 333-266710 221149080 33 71901
2022-08-09 10-Q 10-Q 0000950170-22-016117 001-38537 221148850 34 7633618 1 1
2022-08-09 8-K 8-K 2.02,9.01 0001140361-22-028807 001-38537 221146360 34 301087 1 1
2022-08-01 SC 13G 13G_AVRO_20220729.htm 0001461790-22-000018 005-90532 221122286 34 106273
2022-07-08 SC 13G us05455m1009_070822.txt 0000834237-22-010302 005-90532 221075030 34 12410
2022-06-29 8-K 8-K 5.02,7.01,9.01 0001193125-22-185087 001-38537 221055023 34 23215808 1 1
2022-06-17 3 PRIMARY DOCUMENT 0001127602-22-017780 18217
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017247 7300
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017246 7397
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017245 7276
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017244 7301
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017243 7267
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017242 7295
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017241 7822
2022-06-10 8-K 8-K 5.07,9.01 0001564590-22-022999 001-38537 221009316 34 213800 1 1
2022-05-24 8-K 8-K 7.01,9.01 0001193125-22-157956 001-38537 22953969 34 22911437 1 1
2022-05-18 8-K 8-K 7.01,9.01 0001193125-22-153616 001-38537 22937127 34 182290 1 1
2022-05-17 8-K 8-K 7.01,9.01 0001193125-22-152426 001-38537 22932227 34 12322806 1 1
2022-05-10 10-Q 10-Q 0001564590-22-019306 001-38537 22910260 34 6195449 1 1
2022-05-10 SC 13G/A form242.htm 0001623632-22-000591 005-90532 22908675 34 279587
2022-05-10 8-K 8-K 2.02,9.01 0001193125-22-145656 001-38537 22907311 34 213027 1 1
2022-04-27 DEFA14A DEFA14A 0001564590-22-016134 001-38537 22860744 34 1168192
2022-04-27 DEF 14A DEF 14A 0001564590-22-016125 001-38537 22860612 34 2809069
2022-03-17 S-8 S-8 0001193125-22-078412 333-263655 22749595 33 62850
2022-03-17 10-K 10-K 0001564590-22-010895 001-38537 22749528 34 9515172 1 1
2022-03-17 8-K 8-K 2.02,9.01 0001193125-22-077852 001-38537 22746794 34 221372 1 1
2022-03-09 SC 13G/A FILING AVROBIO, INC. 0000019617-22-000277 005-90532 34 89902
2022-02-14 SC 13G form40.htm 0001623632-22-000222 005-90532 22628710 34 279667
2022-02-14 SC 13G/A PRIMARY DOCUMENT 0001654954-22-001585 005-90532 22626289 34 69472
2022-02-14 SC 13G/A deeptrack-avro123121a1.htm 0001172661-22-000426 005-90532 22625877 34 103124
2022-02-10 SC 13G SCHEDULE 13G - AVROBIO, INC.. 0001106191-22-000010 005-90532 22609022 34 109825
2022-02-09 8-K 8-K 7.01,9.01 0001193125-22-031820 001-38537 22603785 34 7442965 1 1
2022-02-04 4 PRIMARY DOCUMENT 0001127602-22-003428 7264
2022-02-04 4 PRIMARY DOCUMENT 0001127602-22-003427 7349
2022-02-04 4 PRIMARY DOCUMENT 0001127602-22-003426 7299
2022-02-04 4 PRIMARY DOCUMENT 0001127602-22-003424 7299
2022-02-04 4 PRIMARY DOCUMENT 0001127602-22-003423 7311
2022-02-03 SC 13G/A us05455m1009_020322.txt 0000834237-22-006454 005-90532 22589227 34 13302
2022-01-07 8-K 8-K 2.05,5.02 0001193125-22-004476 001-38537 22518404 34 154795 1 1
2022-01-07 SC 13G/A FILING AVROBIO, INC. 0000019617-22-000036 005-90532 34 89908
2022-01-04 8-K 8-K 8.01,9.01 0001193125-22-001034 001-38537 22504041 34 5536036 1 1
2021-11-04 10-Q 10-Q 0001564590-21-054522 001-38537 211380574 34 7107852 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001193125-21-319324 001-38537 211378031 34 221720 1 1
2021-11-02 4 PRIMARY DOCUMENT 0001127602-21-028142 5235
2021-10-27 3 PRIMARY DOCUMENT 0001127602-21-027706 7985
2021-10-19 8-K 8-K 7.01,8.01,9.01 0001193125-21-301529 001-38537 211329632 34 25831717 1 1
2021-08-09 8-K 8-K 8.01,9.01 0001193125-21-239966 001-38537 211154837 34 24362966 1 1
2021-08-05 10-Q 10-Q 0001564590-21-041725 001-38537 211149509 34 6091652 1 1
2021-08-05 SC 13G deeptrack-avro073021.htm 0001172661-21-001581 005-90532 211149409 34 103093
2021-08-05 8-K 8-K 2.02,9.01 0001193125-21-236976 001-38537 211146323 34 219772 1 1
2021-07-08 4 PRIMARY DOCUMENT 0001127602-21-021729 4329
2021-06-17 8-K 8-K 8.01,9.01 0001193125-21-192746 001-38537 211023400 34 25426562 1 1
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019840 5172
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019838 5230
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019836 5216
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019834 9665
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019832 5201
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019830 9605
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019828 9649
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019824 5200
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019822 9614
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019820 9647
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019818 9654
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019817 5712
2021-06-14 4 PRIMARY DOCUMENT 0001127602-21-019804 9751
2021-06-14 8-K 8-K 5.07 0001564590-21-032790 001-38537 211014936 34 43926
2021-05-13 10-Q 10-Q 0001564590-21-027619 001-38537 21920463 34 5588679 1 1
2021-05-13 8-K 8-K 2.02,9.01 0001193125-21-159820 001-38537 21917171 34 216775 1 1
2021-05-03 8-K 8-K 8.01,9.01 0001193125-21-146637 001-38537 21881317 34 26949727 1 1
2021-04-22 DEFA14A DEFA14A 0001564590-21-020141 001-38537 21845366 34 264074
2021-04-22 DEF 14A DEF 14A 0001564590-21-020116 001-38537 21845041 34 1823755
2021-03-23 8-K 8-K 7.01,9.01 0001193125-21-090429 001-38537 21763193 34 27524385 1 1
2021-03-18 S-8 S-8 0001193125-21-085990 333-254466 21755505 33 82088
2021-03-18 10-K 10-K 0001564590-21-014190 001-38537 21754975 34 9505370 1 1
2021-03-18 8-K 8-K 2.02,9.01 0001193125-21-084892 001-38537 21753066 34 221975 1 1
2021-03-10 3 PRIMARY DOCUMENT 0001127602-21-010127 16359
2021-02-18 4 PRIMARY DOCUMENT 0001127602-21-006556 4427
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-024112 005-90532 21639250 34 173709
2021-02-16 SC 13D/A SC 13D/A 0001193125-21-044828 005-90532 21637898 34 99198
2021-02-08 8-K 8-K 7.01,8.01,9.01 0001193125-21-031585 001-38537 21598577 34 26505343 1 1
2021-02-04 4 PRIMARY DOCUMENT 0001127602-21-004043 5278
2021-02-04 4 PRIMARY DOCUMENT 0001127602-21-004042 5192
2021-02-04 4 PRIMARY DOCUMENT 0001127602-21-004041 5193
2021-02-04 4 PRIMARY DOCUMENT 0001127602-21-004040 5240
2021-02-02 4 PRIMARY DOCUMENT 0001127602-21-003526 5224
2021-01-29 SC 13G/A us05455m1009_012821.txt 0000834237-21-002842 005-90532 21566806 34 13453
2021-01-22 3 PRIMARY DOCUMENT 0001127602-21-002340 8014
2021-01-20 SC 13G/A FILING AVROBIO, INC. 0000019617-21-000115 005-90532 34 89906
2021-01-11 8-K 8-K 7.01,9.01 0001193125-21-005755 001-38537 21519078 34 22926077 1 1
2020-12-28 4 PRIMARY DOCUMENT 0001127602-20-032415 9256

Latest XBRL company facts

One latest value per concept from companyfacts (345 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 19.95M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
dei EntityPublicFloat Entity Public Float USD 232.00M 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-076793
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD -1.13M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177467
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.09M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177467
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 243.84 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177467
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 8.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.62M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AccrualForEnvironmentalLossContingenciesForeignCurrencyTranslationGainLoss Accrual for Environmental Loss Contingencies, Foreign Currency Translation Gain (Loss) USD 26,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 803,000 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338062
us-gaap AccruedRentCurrent Accrued Rent, Current USD 177,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001193125-18-325511
us-gaap AccruedUtilitiesCurrent Accrued Utilities, Current USD 100,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.41M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 520.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 572.92M 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 9.30M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.24M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 67,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023269
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 197,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 10.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 37,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap Assets Assets USD 243.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AssetsCurrent Assets, Current USD 238.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 185,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 0 2024-06-30 2024 Q2 10-Q 2024-08-14 0001193125-24-200609
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 85.23M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 319,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 1.99M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 78.16M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap Cash Cash USD 600,000 2020-11-19 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 234.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 235.15M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -19.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 283,000 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023269
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 4.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 19.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 19.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -57.89M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016117
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 15.32M 2018-06-25 2019 Q3 10-Q 2019-11-07 0001564590-19-041704
us-gaap CostsAndExpenses Costs and Expenses USD 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 1.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 16.35M 2022-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 14.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 1.07M 2022-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -380,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 18.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap DeferredRentCredit Deferred Rent Credit USD 292,000 2022-01-01 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 4.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 189.52M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 15.76M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 630,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 123.87M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 453.30M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 8.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 399.30M 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 123.70M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 25.05M 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.75M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 913,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 188.89M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense Deferred Taxes, Business Combination, Valuation Allowance, Available to Reduce Income Tax Expense USD 18.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 630,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 40.30M 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap DeferredTaxLiabilitiesDerivatives Deferred Tax Liabilities, Derivatives USD 101,000 2017-12-31 2018 FY 10-K 2019-03-25 0001193125-19-085321
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 130,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001193125-24-200609
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 388,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.08 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 396,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001193125-18-325511
us-gaap Depreciation Depreciation USD 808,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 584,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-037237
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 839,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 371,000 2017-12-31 2018 FY 10-K 2019-03-25 0001193125-19-085321
us-gaap DividendsCash Dividends, Cash USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.68 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0001564590-22-019306
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.204 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount USD -12,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.001 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.022 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 96,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 400,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.11M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 23.20M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269701
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 162,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 59,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001193125-24-200609
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 103,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 59,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 44,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 284,000 2024-06-30 2024 Q2 10-Q 2024-08-14 0001193125-24-200609
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 287,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 220,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 230,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.104 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap FinancingReceivableReclassificationToHeldForSale Financing Receivable, Reclassification to Held-for-sale USD 2.29M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -1.63M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 3.76M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD 83.74M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 83.74M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost USD 939,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 18.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 940,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 940,000 2023-07-01 2023-09-30 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap IncomeLossAttributableToNoncontrollingInterest Income (Loss) Attributable to Noncontrolling Interest, before Tax USD -12.53M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -73.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -68.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 229,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 77,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 1.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 14.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -15.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 407,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -37,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -72.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount USD 1.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -1.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 531,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -680,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -63,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -56,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -40,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 259,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041704
us-gaap InterestExpenseDebt Interest Expense, Debt USD 1.92M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap InterestExpenseOther Interest Expense, Other USD 18,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 107,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 4,000 2020-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 6.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap InvestmentIncomeNet Investment Income, Net USD 1.15M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2.09M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 4.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 567,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 171,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 769,000 2024-06-30 2024 Q2 10-Q 2024-08-14 0001193125-24-200609
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 814,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap Liabilities Liabilities USD 14.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 243.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LiabilitiesCurrent Liabilities, Current USD 12.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap LineOfCreditFacilityCapacityAvailableForTradePurchases Line of Credit Facility, Capacity Available for Trade Purchases USD 10.00M 2018-09-30 2018 Q3 10-Q 2018-11-13 0001193125-18-325511
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 10.00M 2017-06-23 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap LongTermDebt Long-term Debt USD 15.00M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021318
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 1.88M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021318
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 5.63M 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 5.63M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021318
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 7.50M 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 7.50M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021318
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021318
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 35.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -78,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -54.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -68.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -68.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -68.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 1.61M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap OperatingExpenses Operating Expenses USD 74.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -74.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD -937,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.82M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OperatingLeasePayments Operating Lease, Payments USD 5.30M 2025-09-30 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.23M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.81M 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.03M 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 69,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 706,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.177 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OtherAssetsCurrent Other Assets, Current USD 626,000 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 577,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 37,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 68.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 500,000 2017-12-31 2018 FY 10-K 2019-03-25 0001193125-19-085321
us-gaap OtherNoncashIncomeTaxExpense Other Noncash Income Tax Expense USD 377,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 78,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -119,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap OtherReceivables Other Receivables USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 0 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-104974
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 7.41M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap PaymentsForProceedsFromTenantAllowance Payments for (Proceeds from) Tenant Allowance USD 842,000 2018-01-12 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 55,000 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-13 0001193125-19-145337
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 1.20M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001193125-24-200609
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 204,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054522
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 645,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 98,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 2.24M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap PrepaidInsurance Prepaid Insurance USD 411,000 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap PrepaidRent Prepaid Rent USD 83,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-037237
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 13.07M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-338062
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 4,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 58.26M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 400.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -51,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027619
us-gaap ProceedsFromSaleOfBuildings Proceeds from Sale of Buildings USD 83.74M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap ProceedsFromSaleOfPropertyHeldForSale Proceeds from Sale of Property Held-for-sale USD 185,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062131
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 615,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 27,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -68.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4.59M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 793,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 56.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap RestrictedCash Restricted Cash USD 485,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 492,000 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 485,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.23 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009527
us-gaap RestructuringCharges Restructuring Charges USD 5.30M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -291.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 33.05 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap SecurityDeposit Security Deposit USD 209,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001564590-20-037237
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 9.90M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 11.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 9.63 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 771,600 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 9.63 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 599,850 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 9.64 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 575 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 326,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 15.65 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 2.51 2023-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.834 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.037 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.029 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-212016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-104974
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 2.10M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.64M 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 8.45 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 16,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 21,265 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 56.44 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 296,699 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 934,500 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.79 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031635
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period shares 92,480 2024-01-01 2024-12-31 2025 Q2 10-Q 2025-08-07 0000950170-25-104974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.60M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 12.61 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 16.8 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125304
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price USD/shares 22.69 2024-01-01 2024-12-31 2025 Q3 10-Q 2025-11-06 0001193125-25-269701
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 229.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.53 2024-06-20 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 71,215 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 87.50M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 80.63M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 4,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 173.10M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 156,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 471,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap SubleaseIncome Sublease Income USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-057091
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 2.24M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042648
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 87.50M 2018-03-31 2019 Q1 10-Q 2019-05-13 0001193125-19-145337
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 63.49M 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011144
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 63.30M 2018-03-31 2019 Q1 10-Q 2019-05-13 0001193125-19-145337
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 63.30M 2018-03-31 2019 Q1 10-Q 2019-05-13 0001193125-19-145337
us-gaap TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax Translation Adjustment Functional to Reporting Currency, Gain (Loss), Reclassified to Earnings, Net of Tax USD 59,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 18.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076793
us-gaap VariableLeaseCost Variable Lease, Cost USD 989,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 35,000 2017-12-31 2018 FY 10-K 2019-03-25 0001193125-19-085321
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 19.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 43.70M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0001564590-22-019306
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 19.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450019

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →